2017
DOI: 10.1002/anie.201611685
|View full text |Cite
|
Sign up to set email alerts
|

Diversity‐Oriented Synthesis of Cyclic Azapeptides by A3‐Macrocyclization Provides High‐Affinity CD36‐Modulating Peptidomimetics

Abstract: Macrocyclization has enabled the use of peptides in drug discovery creating a need for methods to synthesize diverse peptide macrocycles. Azapeptides have advanced to clinically used drugs, however, few cyclic azapeptides have been studied. A multiple component "A -macrocyclization" strategy is described for the preparation of diverse cyclic azapeptides and is demonstrated by the synthesis of 15 growth hormone releasing hormone-6 (GHRP-6) analogs. Certain cyclic aza-GHRP-6 analogs exhibited unprecedented affin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
69
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 58 publications
(71 citation statements)
references
References 70 publications
1
69
0
1
Order By: Relevance
“…14 Moreover, 18 F-substitution may offer opportunities for PET-imaging, 15 and for enhancing metabolic stability.16 Unnatural, unsaturated/α-branched amino acids are also of interest as building blocks for modified non-ribosomal peptide synthesis17 and programmed unnatural amino acid mutagenesis at the ribosome.18 Quaternary AAs also find application in driving the formation of useful secondary structure when strategically incorporated into α- 19 and β-peptides 20 as well as hybrid α/β-peptides, 21 or in promoting interesting helical motifs such as the 3 10 -helix 22 and the 2.05-helix. 23 Elements of side chain unsaturation can serve as useful conformational constraints 24 and contribute to overall peptide stability via stapling technology. 25 …”
Section: Introductionmentioning
confidence: 99%
“…14 Moreover, 18 F-substitution may offer opportunities for PET-imaging, 15 and for enhancing metabolic stability.16 Unnatural, unsaturated/α-branched amino acids are also of interest as building blocks for modified non-ribosomal peptide synthesis17 and programmed unnatural amino acid mutagenesis at the ribosome.18 Quaternary AAs also find application in driving the formation of useful secondary structure when strategically incorporated into α- 19 and β-peptides 20 as well as hybrid α/β-peptides, 21 or in promoting interesting helical motifs such as the 3 10 -helix 22 and the 2.05-helix. 23 Elements of side chain unsaturation can serve as useful conformational constraints 24 and contribute to overall peptide stability via stapling technology. 25 …”
Section: Introductionmentioning
confidence: 99%
“…The aza-pipecolyl peptidomimetics were reported to display antibacterial and antidiabetic activities, based on their conformational significance, the synthesis of new modular sulphur containing dipeptide mimetics (diazabicycloalkanes) and azapolycyclic compounds was performed [39]. Few cyclic aza-GHRP-6 analogs exhibited unprecedented affinity for the CD36 receptor and also reduced the pro-inflammatory cytokines [40]. Importance of azapeptides as cysteine and serine protease inhibitors: A number of human diseases are associated with aberrant activity of mammalian, viral, bacterial or parasitic proteases.…”
Section: Various Azapeptide Scaffolds As Peptidomimeticsmentioning
confidence: 99%
“…Recently, azaPra residues have been employed in the so‐called A 3 ‐macrocyclizations to synthesize side chain‐to‐side chain constrained azapeptides (e.g., 1 ), some of which have demonstrated unprecedented binding affinity and modulatory effects on the cluster of differentiation‐36 receptor (CD36). For example, azacyclopeptide 1a exhibited high CD36 binding affinity (IC 50 of 0.08 μm) and suppressed downstream release of pro‐inflammatory cytokines, chemokines, and nitric oxide in macrophages exposed to a Toll‐like receptor agonist . Azacyclopeptide 1a and related analogs are thus promising targets because of potential to mitigate macrophage‐driven inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…The azaPra residue has been installed by a process featuring activation of benzophenone hydrazone ( 6 ) as methylidene carbazate 8 which on reaction with peptide resin 7 gave semicarbazone 9 (Scheme ) . Alkylation of aza‐glycine 9 with propargyl bromide gave protected azaPra 10 , which upon treatment with 1.5 M hydroxylamine hydrochloride in pyridine gave semicarbazide 11 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation